Skip to main content
All lobbying clients

BIOTECHNOLOGY INNOVATION ORGANIZATION

Lobbying client · District of Columbia · filed 2025 to 2026

$9,570,000 Reported spend
6 Filings counted
1 Firms hired
30 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (107792), not by name.

 Firms hired 1
 Bills named in these filings 30
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    6 filings
  • HR 1672
    Maintaining Investments in New Innovation Act
    6 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    5 filings
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    5 filings
  • S 1096
    Preserve Access to Affordable Generics and Biosimilars Act
    5 filings
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
    5 filings
  • S 527
    Prescription Pricing for the People Act of 2025
    5 filings
  • HR 3152
    Patent Eligibility Restoration Act of 2025
    4 filings
  • HR 3160
    PREVAIL Act
    4 filings
  • HR 946
    ORPHAN Cures Act
    4 filings
  • S 1041
    Affordable Prescriptions for Patients Act
    4 filings
  • S 1095
    Stop STALLING Act
    4 filings
  • S 1546
    Patent Eligibility Restoration Act of 2025
    4 filings
  • S 1553
    PREVAIL Act
    4 filings
  • S 2276
    ETHIC Act
    4 filings
  • S 2658
    Medication Affordability and Patent Integrity Act
    4 filings
  • S 43
    Skinny Labels, Big Savings Act
    4 filings
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
    4 filings
  • S 705
    Innovation in Pediatric Drugs Act of 2025
    4 filings
  • S 864
    HELP Copays Act
    4 filings
  • HR 5256
    340B ACCESS Act
    3 filings
  • HR 6423
    HELP Copays Act
    3 filings
  • HR 6485
    Skinny Labels, Big Savings Act
    3 filings
  • S 1302
    Increasing Transparency in Generic Drug Applications Act
    3 filings
  • S 832
    EPIC Act of 2025
    3 filings
  • HR 5391
    Protecting Patient Access to Cancer and Complex Therapies Act
    2 filings
  • S 2082
    Ensuring Justice for Victims of Terrorism Act
    2 filings
  • S 2764
    Protecting Patient Access to Cancer and Complex Therapies Act of 2023
    2 filings
  • HR 3169
    SBIR/STTR Reauthorization Act of 2025
    2 filings
  • HR 3269
    ETHIC Act
    2 filings
 Reported by year 2 years
  • 2026 $3,980,000 2 filings
  • 2025 $5,590,000 4 filings
 Issues lobbied 15

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 24
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • Patent & Trademark Office (PTO) 6
  • SENATE 6
  • Commerce, Dept of (DOC) 5
  • Natl Security Council (NSC) 5
  • White House Office 5
  • Office of Management & Budget (OMB) 4
  • Treasury, Dept of 4
  • U.S. Trade Representative (USTR) 4
  • Centers For Medicare and Medicaid Services (CMS) 3
  • Food & Drug Administration (FDA) 3
  • Natl Economic Council (NEC) 3
  • Small Business Administration (SBA) 3
  • Federal Trade Commission (FTC) 2
  • Natl Institutes of Health (NIH) 2
  • Office of Science & Technology Policy (OSTP) 2
  • Office of the Vice President of the United States 2
  • Agriculture, Dept of (USDA) 1
  • Council of Economic Advisers (CEA) 1
  • Energy, Dept of 1
  • Justice, Dept of (DOJ) 1
  • Securities & Exchange Commission (SEC) 1
  • State, Dept of (DOS) 1

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem